VDyne Appoints Mike Buck as Chairman and CEO to Lead Next Phase of its TTVR Program
VDyne Inc. (“VDyne”), a privately held medical device company developing a transcatheter tricuspid valve replacement (TTVR) system to treat tricuspid regurgitation, today announced the appointment of Mike Buck as Chairman and Chief Executive Officer.
